References
- Leibowitz MR, Derman DP, Jacobson R, Stevens K, Katz J. Chronic myeloid leukaemia in South African blacks. S Afr Med J. 1976;50:2035–7.
- Boma PO, Durosinmi MA, Adediran IA, Akinola NO, Salawu L. Clinical and prognostic features of Nigerians with chronic myeloid leukemia. Niger Postgrad Med J. 2006;13:47–52.
- Othieno-Abinya NA, Nyabola LO, Kiarie GW, Ndege R, Maina JM. Chronic myeloid leukaemia at the Kenyatta National Hospital, Nairobi. East Afr Med J. 2002;79:593–7.
- Mukiibi JM, Nyirenda CM, Paul B, Adewuyi JO, Mzula EL, Malata HN. Chronic myeloid leukaemia in central Africans. East Afr Med J. 2003;80:470–5.
- O’Hare T, Deininger MW. Toward a cure for chronic myeloid leukemia. Clin Cancer Res. 2008;14:7971–4.
- Louw VJ, Nel TJ, Leipoldt EJ, Badenhorst PN, Hay JF, Nel MM. Challenges in transfusion medicine recruitment and training–a solution. Transfus Med. 2010;20:70–1.
- Baccarani M, Cortes J, Pane F, Niederwieser D, Saglio G, Apperley J, et al.. Chronic myeloid leukemia: an update of concepts and management recommendations of European LeukemiaNet. J Clin Oncol. 2009;27:6041–51.
- Louw VJ, Dreosti L, Ruff P, Jogessar V, Moodley D, Novitzky N, et al.. Recommendations for the management of adult chronic myeloid leukaemia in South Africa. S Afr Med J. 2011;101:840–6.
- Novitzky N, Rubinstein R, Hallett JM, du Toit CE, Thomas VL. Bone marrow transplantation depleted of T cells followed by repletion with incremental doses of donor lymphocytes for relapsing patients with chronic myeloid leukemia: a therapeutic strategy. Transplantation. 2000;69:1358–63.
- Coetzee MJ, Louw VJ, Gartrell K, Viljoen CD. Chakalaka-induced vasodilatation in patients with chronic myeloid leukaemia on tyrosine kinase inhibitors. S Afr Med J. 2009;99:870–1.